In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
Hello Health Rounds Readers! Today we feature a sneak peek at a trio of studies to be presented at the American Heart ...
The increases were particularly marked among middle-aged men, Black adults, residents of Midwestern states and ...
The Category III CPT code reflects SENSORA's growing role as an essential tool in cardiac care and is expected to expand its ...
Capucia Publishing is proud to introduce Quantum Rebel, the latest book by Chindia Ilonka, a global leader in human transformation and organizational effectiveness. In this powerful new release, ...
A new study links smoking, high blood pressure, and atrial fibrillation to a heightened risk of severe, disabling strokes.
The researchers revealed that for atrial fibrillation after cardiac surgery (AFACS) prophylaxis, supplementing potassium only ...
Development of the coronavirus disease 2019 (COVID-19) vaccine has been key to countering the pandemic caused by severe acute ...
Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.